Systemic, local, and sclerotherapy drugs: What do we know about drug prescribing in vascular anomalies?-Reference-Cited by-同舟云学术

Systemic, local, and sclerotherapy drugs: What do we know about drug prescribing in vascular anomalies?

Published:2021-10 Issue:12 Volume:68 Page:
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Marcoux Simon¹²^ORCID,Théorêt Yves³²^ORCID,Dubois Josée⁴⁵^ORCID,Essouri Sandrine⁵⁶⁷^ORCID,Pincivy Alix⁸^ORCID,Coulombe Jérôme⁵⁹^ORCID,McCuaig Catherine⁵⁹^ORCID,Powell Julie⁵⁹^ORCID,Soulez Gilles¹⁰^ORCID,Kleiber Niina³²⁵⁶⁷^ORCID

Affiliation:

1. Faculty of Medicine Université de Sherbrooke Sherbrooke Quebec Canada

2. Clinical Pharmacology Unit, CHU Sainte‐Justine Université de Montréal Montréal Quebec Canada

3. Department of Pharmacology and Physiology Université de Montréal Montréal Quebec Canada

4. Department of Radiology, CHU Sainte‐Justine Université de Montréal Montréal Quebec Canada

5. Vascular Anomaly Team, CHU Sainte‐Justine Université de Montréal Montréal Quebec Canada

6. Division of General Pediatrics, Department of Pediatrics CHU Sainte‐Justine, Université de Montréal Montréal Quebec Canada

7. Research Center, CHU Sainte‐Justine Université de Montréal Montréal Quebec Canada

8. Library, CHU Sainte‐Justine Université de Montréal Montréal Quebec Canada

9. Division of Dermatology Department of Pediatrics, CHU Sainte‐Justine Université de Montréal Montréal Quebec Canada

10. Department of Radiology Centre Hospitalier de l'Université de Montréal (CHUM) Montréal Quebec Canada

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/pbc.29364

Reference41 articles.

1. Advances in the Medical Management of Vascular Anomalies

2. Vascular Anomalies

3. Off-Label Use and Safety of Drug Use in Vascular Anomalies

4. ISSVA Classification of Vascular Anomalies 2018.International Society for the Study of Vascular Anomalies.2018.

5. The Oxford 2011 Levels of Evidence.Oxford Centre for Evidence‐Based Medicine.2011.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review;Children;2022-08-26

2. Defining vascular anomaly phenotypes in children based on a systematic literature search: A critical step in developing a single severity score for interventional clinical trials;Pediatric Blood & Cancer;2022-07-20

3. Evaluating the Non-conventional Achalasia Treatment Modalities;Frontiers in Medicine;2022-06-24

4. Update December 2021;Lymphatic Research and Biology;2021-12-01